Entries Tagged as 'Media'

Monday, March 30th, 2015

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Tuesday, January 6th, 2015

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Thursday, September 26th, 2013

Drugs.com Recognizes American Pharmacists Month

Pharmacists Recognized for Their Valuable Role in Healthcare October is a special month here at Drugs.com – it’s American Pharmacists Month, spearheaded by the American Pharmacists Association (APhA). We are pharmacists ourselves, so naturally we like to take time this month to recognize the many pharmacists in the U.S. that work to improve patient care, […]

Thursday, August 8th, 2013

Q2 2013 Drug Sales Data Released: Humira Climbs and Posts Double-Digit Growth

The latest U.S. drug sales data has been released by Drugs.com. Since Q2 2012, Otuska’s antipsychotic Abilify and AstraZeneca’s acid reducer Nexium have held either the number one or two spot in top dollar sales. This quarter, both agents continue to maintain their stronghold; each post close to $1.5 billion in sales. Humira, AbbVie’s key […]

Sunday, May 5th, 2013

Q1 2013 Drug Sales Data Released: Rough U.S Flu Season Boosts Numbers for Tamiflu

The latest U.S. drug sales data has been released by Drugs.com. The top five drugs have minor shifts in rank but exhibit positive growth for Q1 2013. Abilify, Otsuka’s second generation antipsychotic, and Nexium, AstraZeneca’s leading acid blocker, rank as the top two drugs by sales for the fourth quarter in a row. Both agents […]

Tuesday, April 9th, 2013

Drugs.com Receives Fourth Webby Nomination!

We are extremely proud to announce that Drugs.com has been nominated for the prestigious Webby Awards. Kudos to the hard working team! This is their fourth nomination in five years. To yet again be judged among the Internet’s top 5 health web sites is indeed an honor. But wait, there’s more… we need your vote! The […]

Monday, January 28th, 2013

Drugs.com Pill Reminder featured on Fox Television Orlando

Our popular Pill Reminder app was featured on WOFL Fox 35 Orlando recently. Here’s what they had to say… “People need to take a medicine to keep that blood pressure down and it’s hard to motivate them,” said Dr. Timothy Hendrix of Centra Care. “It’s hard to remind them to take that everyday if they’re […]

Tuesday, December 18th, 2012

Transparency in Clinical Trials: A New Paradigm Shift?

The British Medical Journal (BMJ), a leading, peer-reviewed medical journal, has announced that beginning in January 2013 it will require all authors of drug or device clinical trials who publish in BMJ – whether industry-funded or not – to provide detailed scientific study data to anyone with a reasonable request. Although the policy specifics are […]

Wednesday, August 22nd, 2012

Q2 2012 Drug Sales Data Released: Loss of Patent Protection Has Significant Effect

The latest U.S. drug sales data has been released by Drugs.com. Proton-pump inhibitors, antipsychotics, asthma therapeutics and statins remain the top selling categories. Plavix and Seroquel dipped in the second quarter due to loss of patent protection. Other top brands such as Singulair, Actos and Diovan are also due to be impacted by year’s end. […]

Wednesday, July 7th, 2010

July 13 Webinar – FDA’s Safety Monitoring of Approved Vaccines

FDA’s Center for Biologics Evaluation and Research will host a 30-minute webinar on the agency’s efforts to ensure the safety of vaccines. There will be an opportunity to ask questions following the presentation on July 13, 2010, at 2:00 p.m. EDT. More information is available here: http://www.drugs.com/fda-consumer/july-13-webinar-fda-s-safety-monitoring-of-approved-vaccines-147.html See also, timely FDA Consumer Updates here: http://www.drugs.com/fda-consumer